These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 15135087

  • 21. In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method.
    Xia ZL, Ying JY, Sheng R, Zeng S, Hu YZ, Yao TW.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 01; 857(2):266-74. PubMed ID: 17709305
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
    Fang J, McKay G, Song J, Remillrd A, Li X, Midha K.
    Drug Metab Dispos; 2001 Dec 01; 29(12):1638-43. PubMed ID: 11717183
    [Abstract] [Full Text] [Related]

  • 27. A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.
    Ohyama K, Nakajima M, Nakamura S, Shimada N, Yamazaki H, Yokoi T.
    Drug Metab Dispos; 2000 Nov 01; 28(11):1303-10. PubMed ID: 11038157
    [Abstract] [Full Text] [Related]

  • 28. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP, Crews BC, Kozak KR, Kalgutkar AS, Marnett LJ.
    Drug Metab Dispos; 2004 Jan 01; 32(1):113-22. PubMed ID: 14709628
    [Abstract] [Full Text] [Related]

  • 29. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
    Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, Vachharajani N, Mitroka J.
    Drug Metab Dispos; 2005 Apr 01; 33(4):500-7. PubMed ID: 15640381
    [Abstract] [Full Text] [Related]

  • 30. Fipronil induces CYP isoforms in rats.
    Caballero MV, Ares I, Martínez M, Martínez-Larrañaga MR, Anadón A, Martínez MA.
    Food Chem Toxicol; 2015 Sep 01; 83():215-21. PubMed ID: 26142839
    [Abstract] [Full Text] [Related]

  • 31. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):193-209. PubMed ID: 15364537
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitive effect of diphenytriazol on rat cytochrome P450 enzyme in vitro.
    Hu YZ, Yao TW.
    Pharmazie; 2009 Jul 15; 64(7):455-60. PubMed ID: 19694183
    [Abstract] [Full Text] [Related]

  • 34. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
    McGinnity DF, Griffin SJ, Moody GC, Voice M, Hanlon S, Friedberg T, Riley RJ.
    Drug Metab Dispos; 1999 Sep 15; 27(9):1017-23. PubMed ID: 10460801
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions.
    Vickers AE, Sinclair JR, Zollinger M, Heitz F, Glänzel U, Johanson L, Fischer V.
    Drug Metab Dispos; 1999 Sep 15; 27(9):1029-38. PubMed ID: 10460803
    [Abstract] [Full Text] [Related]

  • 37. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE, King I, Paris BL, Haupt L, Ndikum-Moffor F, Campbell R, Usuki E, Skibbe J, Brobst D, Ogilvie BW, Parkinson A.
    Drug Metab Dispos; 2009 Sep 15; 37(9):1922-30. PubMed ID: 19520774
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
    McGinnity DF, Parker AJ, Soars M, Riley RJ.
    Drug Metab Dispos; 2000 Nov 15; 28(11):1327-34. PubMed ID: 11038161
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
    Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S.
    Life Sci; 2004 Apr 16; 74(22):2769-79. PubMed ID: 15043991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.